Journal of Vascular Surgery
Volume 46, Issue 5 , Pages 870-875 , November 2007

Comparison between early and late carotid endarterectomy for symptomatic carotid stenosis in relation to oxidized low-density lipoprotein and plaque vulnerability

Received 16 February 2007 ,Accepted 11 June 2007.

References 

  1. European Carotid Surgery Trialists’ Collaborative Group, MRC European Carotid Surgery Trial. Interim results for symptomatic patients with severe (70-99%), or with mild (0-29%), carotid stenosis. Lancet. 1991;337:1235–1243
  2. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  3. Blaisdell WF, Clauss RH, Galbraith JG, Imparato AM, Wylie EJ. Joint study of extracranial arterial occlusion. IV. A review of surgical considerations. JAMA. 1969;209:1889–1895
  4. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–924
  5. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke. 2004;35:2855–2861
  6. Paty PS, Darling RC, Feustel PJ, Bernardini GL, Mehta M, Ozsvath KJ, et al. Early carotid endarterectomy after acute stroke. J Vasc Surg. 2004;39:148–154
  7. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, et al. Carotid endarterectomy: an evidence-based review—report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65:794–801
  8. Glass CK, Witztum JL. Atherosclerosis (The road ahead). Cell. 2001;104:503–516
  9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  10. Nishi K, Uno M, Fukuzawa K, Horiguchi H, Shinno K, Nagahiro S. Clinicopathological significance of lipid peroxidation in carotid plaque. Atherosclerosis. 2002;160:289–296
  11. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol. 2002;22:1649–1654
  12. Uno M, Kitazato KT, Suzue A, Itabe H, Hao L, Nagahiro N. Contribution of an imbalance between oxidant-antioxidant systems to plaque vulnerability in patients with carotid artery stenosis. J Neurosurg. 2005;103:518–525
  13. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaka T, et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions (Complex formation of oxidized phosphatidylcholines and polypeptides). J Biol Chem. 1994;269:15274–15279
  14. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res. 1996;37:45–53
  15. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955–1960
  16. Ehara S, Ueda M, Naruko T, Haze K, Matsuo T, Ogami M, et al. Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases. J Diabetes Complications. 2002;16:60–64
  17. Kohno H, Sueshige N, Oguri K, Izumidate H, Masunari T, Kawamura M, et al. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. Clin Biochem. 2000;33:243–253
  18. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, et al. Circulating oxidized low density lipoprotein levels (A biochemical risk marker for coronary heart disease). Arterioscler Thromb Vasc Biol. 2000;20:2243–2247
  19. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies—part I. Circulation. 2003;108:1664–1672
  20. Blaser T, Hofmann K, Buerger T, Effenberger O, Wallesch CW, Goertler M. Risk of stroke, transient ischemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. Stroke. 2002;33:1057–1062
  21. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320–2328
  22. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques (Potential role of matrix-degrading metalloproteinases and implications for plaque rupture). Circulation. 1995;92:1565–1569
  23. Xu XP, Meisel SR, Ong JM, Kaul S, Cercek B, Rajavashisth TB, et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 1999;99:993–998

 Competition of interest: none.

 Supported by Grant-in-Aid for Research C2 (No. 19591681) from the Ministry of Education, Science, Sports, and Culture of Japan.

PII: S0741-5214(07)01058-0

doi: 10.1016/j.jvs.2007.06.039

Journal of Vascular Surgery
Volume 46, Issue 5 , Pages 870-875 , November 2007

Article Tools

* Image Usage & Resolution